is ozempic glp-1 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation to stop before conception and discuss 1 in 8 adults in

Weight loss, achieved through a combination of diet, exercise, and lifestyle changes, can help improve GLP-1 levels and insulin sensitivity

The Truth Emerges On July 29, 2025, Novo issued a press release and held a conference call lowering its sales and profit outlook for 2025, citing "lowered growth expectations for the second half of 2025" for both Wegovy and Ozempic due to "the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition." Management also noted that despite the expiry of the FDA grace period for mass compounding on May 22, 2025, company research showed that unsafe and unlawful mass compounding continued

"It blunts that craving that pulls people toward whatever they're addicted to." Developers of GLP-1 agonists and independent investigation teams are taking the potential seriously, with numerous clinical trials prospectively testing these agents for SUDs

The key is that not all electrolyte products are the same

These options may not be popular, on TikTok but they are based on what works for bariatric patients